Danaher had a disappointing 2024. Your path to success next year passes through Wall Street
Life sciences company Danaher certainly hasn't been an easy stock to buy this year. A wave of new companies going…
S&P 500 Index
Eli Lilly seeks to extend its winning streak in the general market to 6 years
Eli Lilly has outperformed the S&P 500 for five straight years as Wall Street realized its huge opportunity in obesity…
Dental Supply Stocks Rise Due to RFK's Anti-Fluoride Stance and Activist Involvement
Robert F. Kennedy Jr. attends a campaign event for Republican presidential candidate and former US President Donald Trump in Milwaukee,…
Palo Alto Stocks Boosted by Contract News, Abbott Labs Braces for Ruling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Abbott Labs shines with strong quarter and buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and raised its profit forecasts for the third consecutive…
GE Healthcare has been an under-the-radar winner and a new catalyst has just arrived
GE Healthcare's quiet outperformance is becoming harder to ignore, and its new drug used in radiology to improve the diagnosis…
10 things to watch in the stock market on Friday, including a bullish call on Best Buy
Ten Things to Watch for Friday, September 27 1. The S&P 500 was pointing to a slightly higher open on…
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
Family offices are more optimistic than ever, according to a survey
A version of this article first appeared on CNBC's Inside Wealth with Robert Frank, a weekly guide for high-net-worth investors…
Tapestry-Capri antitrust trial: Michael Kors testifies
NEW YORK — In federal court on Monday, famed fashion designer Michael Kors spoke out about the daunting challenge of…